Search Results - "Parana, Raymundo"

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy by Yurdaydin, Cihan, Abbas, Zaigham, Buti, Maria, Cornberg, Markus, Esteban, Rafael, Etzion, Ohad, Gane, Edward J., Gish, Robert G., Glenn, Jeffrey S., Hamid, Saeed, Heller, Theo, Koh, Christopher, Lampertico, Pietro, Lurie, Yoav, Manns, Michael, Parana, Raymundo, Rizzetto, Mario, Urban, Stephan, Wedemeyer, Heiner, Wranke, A., Pinheiro Borzacov, L.M., Lobato, C., Hamid, S., Ceausu, E., Dalekos, G.N., Turcanu, A., Niro, G.A., Lubna, F., Abbas, M., Ingiliz, P., Ferenci, P., Vanwolleghem, T., Hayden, T., Dashdorj, N., Motoc, A., Hardtke, S.

“…Chronic hepatitis delta represents the most severe form of chronic viral hepatitis. The current treatment of hepatitis delta virus (HDV) infection consists of…”
Get full text

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease by Arab, Juan Pablo, Dirchwolf, Melisa, Álvares-da-Silva, Mário Reis, Barrera, Francisco, Benítez, Carlos, Castellanos-Fernandez, Marlene, Castro-Narro, Graciela, Chavez-Tapia, Norberto, Chiodi, Daniela, Cotrim, Helma, Cusi, Kenneth, de Oliveira, Claudia Pinto Marques Souza, Díaz, Javier, Fassio, Eduardo, Gerona, Solange, Girala, Marcos, Hernandez, Nelia, Marciano, Sebastián, Masson, Walter, Méndez-Sánchez, Nahum, Leite, Nathalie, Lozano, Adelina, Padilla, Martín, Panduro, Arturo, Paraná, Raymundo, Parise, Edison, Perez, Marlene, Poniachik, Jaime, Restrepo, Juan Carlos, Ruf, Andrés, Silva, Marcelo, Tagle, Martín, Tapias, Monica, Torres, Kenia, Vilar-Gomez, Eduardo, Costa Gil, José Eduardo, Gadano, Adrian, Arrese, Marco

“…Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting…”
Get full text

Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver by Bessone, Fernando, Hernandez, Nelia, Tagle, Martin, Arrese, Marco, Parana, Raymundo, Méndez-Sánchez, Nahum, Ridruejo, Ezequiel, Mendizabal, Manuel, Dagher, Lucy, Contreras, Fernando, Fassio, Eduardo, Pessoa, Mario, Brahm, Javier, Silva, Marcelo

“…Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting…”
Get full text

IL‐22 and IL‐22 binding protein (IL‐22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections by Sertorio, Mathieu, Hou, Xunya, Carmo, Rodrigo F., Dessein, Hélia, Cabantous, Sandrine, Abdelwahed, Mohammed, Romano, Audrey, Albuquerque, Fernanda, Vasconcelos, Luydson, Carmo, Theomira, Li, Jun, Varoquaux, Arthur, Arnaud, Violaine, Oliveira, Pablo, Hamdoun, Anas, He, Hongbin, Adbelmaboud, Suzan, Mergani, Adil, Zhou, Jie, Monis, Ahmed, Pereira, Leila Beltrao, Halfon, Philippe, Bourlière, Marc, Parana, Raymundo, dos Reis, Mitermayer, Gonnelli, David, Moura, Patricia, Elwali, Nasr Eldin, Argiro, Laurent, Li, Yuesheng, Dessein, Alain

“…Interleukin (IL)‐22 acts on epithelia, hepatocytes, and pancreatic cells and stimulates innate immunity, tissue protection, and repair. IL‐22 may also cause…”
Get full text

Serious liver injury induced by Nimesulide: an international collaborative study by Bessone, Fernando, Hernandez, Nelia, Mendizabal, Manuel, Ridruejo, Ezequiel, Gualano, Gisela, Fassio, Eduardo, Peralta, Mirta, Fainboim, Hugo, Anders, Margarita, Tanno, Hugo, Tanno, Federico, Parana, Raymundo, Medina-Caliz, Inmaculada, Robles-Diaz, Mercedes, Alvarez-Alvarez, Ismael, Niu, Hao, Stephens, Camilla, Colombato, Luis, Arrese, Marco, Reggiardo, M. Virginia, Ono, Suzane Kioko, Carrilho, Flair, Lucena, M. Isabel, Andrade, Raul J.

“…Nimesulide is a non-steroidal anti-inflammatory drug still marketed in many countries. We aim to analyze the clinical phenotype, outcome, and histological…”
Get full text

Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C by Buti, Maria, Agarwal, Kosh, Horsmans, Yves, Sievert, William, Janczewska, Ewa, Zeuzem, Stefan, Nyberg, Lisa, Brown, Robert S, Hézode, Christophe, Rizzetto, Mario, Paraná, Raymundo, De Meyer, Sandra, De Masi, Ralph, Luo, Donghan, Bertelsen, Kirk, Witek, James

“…Background & Aims We performed an open-label, multicenter, phase 3 study of the safety and efficacy of twice-daily telaprevir in treatment-naive patients with…”
Get full text

Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B by Ferraz, Maria Lucia, Strauss, Edna, Perez, Renata Mello, Schiavon, Leonardo Lucca, Ono, Suzane Kioko, Pessoa, Mario Guimarães, Ferreira, Adalgisa Paiva, Nabuco, Leticia, Carvalho-Filho, Roberto, Tovo, Cristiane Valle, Souto, Francisco, Abrão, Paulo, Reuter, Tania, Dantas, Thor, Vigani, Aline, Porta, Gilda, Ferreira, Marcelo Simão, Paraná, Raymundo, Cimerman, Sergio, Bittencourt, Paulo Lisboa

“…Chronic hepatitis B is an important health problem that can progress to cirrhosis and complications such as hepatocellular carcinoma. There is approximately…”
Get full text

HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases? by Silva, Marcelo Costa, Silva, Carolina Alves Costa, Machado, Gustavo Uzêda, Atta, Ajax, M. Freire, Songeli, Carvalho, Edgar, Schinoni, Maria Isabel, Paraná, Raymundo

“…Hepatitis C virus (HCV) and human T‐lymphotropic virus type 1 (HTLV‐1) coinfection occurs in many regions. However, few studies have focused on the natural…”
Get full text

The influence of drug properties and host factors on delayed onset of symptoms in drug‐induced liver injury by Gonzalez‐Jimenez, Andres, McEuen, Kristin, Chen, Minjun, Suzuki, Ayako, Robles‐Diaz, Mercedes, Medina‐Caliz, Inmaculada, Bessone, Fernando, Hernandez, Nelia, Arrese, Marco, Parana, Raymundo, Lucena, M. Isabel, Stephens, Camilla, Andrade, Raúl J.

“…Background & Aims Most patients with drug‐induced liver injury (DILI) manifest clinical symptoms while on therapy, while some patients manifest days or weeks…”
Get full text

Mutations associated with drug resistance and prevalence of vaccine escape mutations in patients with chronic hepatitis B infection by dos Santos, Maria Isabel Magalhães A., Pacheco, Sidelcina Rugieri, Stocker, Andreas, Schinoni, Maria Isabel, Paraná, Raymundo, Reis, Mitermayer G., Silva, Luciano K.

“…The Brazilian public health system (SUS) has provided antiviral drugs for chronic hepatitis B treatment for over 10 years, but a system for monitoring for…”
Get full text

O-39 CLINICAL CHARACTERISTICS AND OUTCOME OF DRUG-INDUCED LIVER INJURY DUE TO ANTINEOPLASTIC AND BIOLOGICAL AGENTS by Bessone, Fernando, Hernandez, Nelia, Parana, Raymundo, Schinoni, Maria Isabel, Mendizabal, Manuel, Sanchez, Adriana, Nunes, Vinicius, Ridruejo, Ezequiel, Schiodi, Daniela, Fassio, Eduardo, Tanno, Hugo, Tamagnone, Norberto, Tagle, Martin, Montes, Pedro, Medina-Caliz, I, Robles-Díaz, Mercedes, Ortega-Alonso, Aida, García-Cortes, Miren, Niu, Hao, Alvarez-Alvarez, Ismael, Romero-Flores, Rocío, Lucena, M Isabel, Andrade, Raul J

“…Idiosyncratic drug-induced liver injury (DILI) caused by antineoplastic and biological agents is an emerging clinical burden in oncologic patients. However,…”
Get full text

Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia by Atta, Maria, Cabral, Milena, Santos, Gilvan, Paraná, Raymundo, Atta, Ajax

“…Objective This work investigated the profile of inflammation biomarkers in patients with chronic hepatitis C and its association with liver fibrosis, hepatic…”
Get full text

Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy by Codes, Liana, Asselah, Tarik, Cazals-Hatem, Dominique, Tubach, Florence, Vidaud, Dominique, Paraná, Raymundo, Bedossa, Pierre, Valla, Dominique, Marcellin, Patrick

“…Background and aims: The rates of fibrosis progression in chronic hepatitis C are significantly different between males and females. The antifibrogenic effect…”
Get full text

Poor Oral Health-Related Quality of Life in Pre- and Post-Liver Transplantation Patients by Santos-Lins, Larissa S., Aguiar, Inácio L.S., Codes, Liana, Evangelista, Maria A., de Oliveira Castro, Alessandra, L. Bittencourt, Paulo, Cavalcanti, Andrea, Paraná, Raymundo, Lins-Kusterer, Liliane

“…Background: Oral health is associated with Chronic Liver Disease (CLD) and may play a relevant role in oral (OHRQoL) and general health-related quality of life…”
Get full text

Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection by Sousa, Gabriel M., Oliveira, Isabela S., Andrade, Luis J.O., Sousa-Atta, Maria Luiza B., Paraná, Raymundo, Atta, Ajax M.

“…► A decrease in the IL-I7F/IL-22 ratio is observed in chronic hepatitis C. ► IL-17F serum levels are increased in HCV patients with high ALT levels. ► Serum…”
Get full text

Quality of life, work ability and oral health among patients with chronic liver diseases by Aguiar, I, Lins-Kusterer, L, Lins, L-S-S, Paraná, R, Bastos, J, Carvalho, F-M

“…This study aimed to explore the associations between health-related quality of life and work ability with the oral health status of patients with chronic liver…”
Get full text

O-28 DRUG-INDUCED LIVER INJURY IN LATINAMERICA: First ten years’ experience of the ongoing LATINDILI Network by Bessone, Fernando, Hernandez, Nelia, Parana, Raymundo, Mendizabal, Manuel, Sanchez, Adriana, Nunes, Vinicius, Ridruejo, Ezequiel, Schiodi, Daniela, Santos, Genario, Fassio, Eduardo, I., Schinoni Maria, Tanno, Hugo, Tagle, Martin, Montes, Pedro, Arrese, Marco, Mendez-Sanchez, Nahum, Brahm, Javier, Girala, Marcos, Lizarzábal M., Isabel, Mengual, Edgardo, Carrera, Enrique, Contreras, Fernando, Medina-Caliz, Inmaculada, Robles-Díaz, Mercedes, Ortega-Alonso, Aida, García-Cortes, Miren, Alvarez-Alvarez, Ismael, Niu, Hao, Bonilla, Elvira, Lucena M., Isabel, J., Andrade Raul

“…In 2011, the Latin-American DILI-Network (LATINDILIN) set up under the guidance of the Spanish DILI Registry a network of hepatologists to prospectively…”
Get full text

Association between hepatitis C and hepatocellular carcinoma by de Oliveria Andrade, Luis Jesuino, D'Oliveira, Argemiro, Melo, Rosangela Carvalho, De Souza, Emmanuel Conrado, Costa Silva, Carolina Alves, Paraná, Raymundo

“…Hepatocellular carcinoma (HCC) is the fifth most common cancer, the third most common cause for cancer death in the world, a major cause of death in patients…”
Get full text

HBV epidemiology in Latin America by Paraná, Raymundo, Almeida, Delvone

“…In Latin America, despite the paucity of population studies, hepatitis B is considered endemic. The western Amazonia is a highly endemic area where hepatitis D…”
Get full text

Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin by Oliveira, Isabela S., Carvalho, Lucas P., Schinoni, Maria Isabel, Paraná, Raymundo, Atta, Ajax M., Sousa Atta, Maria Luiza B.

“…Chronic infection with hepatitis C virus (HCV) causes a quantitative and functional alteration in innate and adaptative immunity. In the present work, we…”
Get full text